|Bid||0.4500 x 0|
|Ask||0.4700 x 0|
|Day's Range||0.4450 - 0.4800|
|52 Week Range||0.0390 - 0.6050|
|Beta (5Y Monthly)||0.01|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
HMS Holdings Corp. (HMSY), a leading U.S.-based provider of healthcare technology, analytics and engagement solutions, today announced that HMS, through a subsidiary, will make a strategic investment of $7.5 million (US) in ordinary shares of MedAdvisor Limited (ASX:MDR), Australia’s leading digital medication management company. HMS intends to fund the investment with cash on hand. Upon completion of the transaction, HMS will hold an approximate 13% ownership stake in MedAdvisor.
MedAdvisor International to Present at the Planet MicroCap Showcase 2019 on May 1 in Las Vegas, NV MELBOURNE, AUSTRALIA / ACCESSWIRE / April 23, 2019 / MedAdvisor International (ASX: MDR) , Australia's ...